CSI Market
Sign In | Register

Calliditas Therapeutics Ab (CALT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CALT Annual Balance Sheets →
Looking at balance sheet data from Calliditas Therapeutics Ab through 0 provides insight into Jun 30 2024's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2024)
(Dec 31 2023) 0 0 0
Assets
Cash & cash equivalent0.00
Cash, Cash Equivalents Other75.22
Cash & Short-term Investments75.00
Trade & Other Current Receivables (IFRS combined total)-
Inventories3.79
Other Current Assets29.91
Total Current Assets108.92
Goodwill net4.51
Intangible Assets39.99
Intangible AssetsAnd Goodwill11.42
Total Assets164.84
Liabilities
Accounts Payable14.25
Longterm Borrowings92.69
Total Current Liabilities40.55
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent114.22
Total Liabilities154.76
Stockholders' Equity
Common Stockholder's Equity10.07
Total Stockholder's Equity10.07
Liabilities & Stockholder's Equity164.84
4 historic quarters locked

Sign in to unlock the full Calliditas Therapeutics Ab balance sheet history.

Sign In Create Free Account

About Calliditas Therapeutics Ab Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001410578-24-000528

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.